Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
2024年10月9日 - 5:05AM
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or
“Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company
focused on the oral delivery of biologics and drugs, today
announced that the company’s Chief Executive Officer, Talat Imran,
and Chief Financial Officer, Svai Sanford, will participate in a
fireside chat at the 2024 Maxim Healthcare Virtual Summit on
Thursday, October 17, 2024 from 11:30 am – 12:00 pm E.T. in Track
2.
Interested parties can register and access the
live webcast for the conference here.
About Rani Therapeutics
Rani Therapeutics is a clinical-stage
biotherapeutics company focused on advancing technologies to enable
the development of orally administered biologics and drugs. Rani
has developed the RaniPill® capsule, which is a novel, proprietary
and patented platform technology, intended to replace subcutaneous
injection or intravenous infusion of biologics and drugs with oral
dosing. Rani has successfully conducted several preclinical and
clinical studies to evaluate safety, tolerability and
bioavailability using RaniPill® capsule technology. For more
information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
Rani Therapeutics (NASDAQ:RANI)
過去 株価チャート
から 11 2024 まで 12 2024
Rani Therapeutics (NASDAQ:RANI)
過去 株価チャート
から 12 2023 まで 12 2024